Concepedia

Rob Eager

RE

Statistics

Publications

3

Citations

164

H-Index

3

Active since

2000

Affiliations

Mary Crowley Cancer Research Center(Current)

Rob Eager is an author at Mary Crowley Cancer Research Center specializing in cancer pharmacology, oncology, and pharmacology.

Publications per year

2000–2009

3

Publications

3

Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer

Rob Eager, Charles Cunningham, Neil Senzer et al. · Clinical Oncology · 2009 · 89 citations

, , +14

Phase I Study of Oral CI-994 in Combination with Gemcitabine in Treatment of Patients with Advanced Cancer

John Nemunaitis, Douglas Orr, Rob Eager et al. · The Cancer Journal · 2003 · 55 citations

, , +17

Phase I Assessment of the Pharmacokinetics, Metabolism, and Safety of Emitefur in Patients With Refractory Solid Tumors

John Nemunaitis, Rob Eager, T. Twaddell et al. · Journal of Clinical Oncology · 2000 · 20 citations

, , +14

1–3 of 3